Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

BACKGROUND: The outcomes of patients with stage III cutaneous melanoma who undergo complete surgical resection can be highly variable, and estimation of individual risk of disease recurrence and mortality remains imprecise. With recent demonstrations of effective adjuvant targeted and immune checkpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, J H, Saw, R P, Thompson, J F, Lo, S, Spillane, A J, Shannon, K F, Stretch, J R, Howle, J, Menzies, A M, Carlino, M S, Kefford, R F, Long, G V, Scolyer, R A, Rizos, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551453/
https://www.ncbi.nlm.nih.gov/pubmed/30860590
http://dx.doi.org/10.1093/annonc/mdz075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551453/
https://www.ncbi.nlm.nih.gov/pubmed/30860590
http://dx.doi.org/10.1093/annonc/mdz075

Ejemplares similares